Conference Material
|
Slide Presentation
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
Fahal AH,
Ahmed ES,
Bakhiet SM,
Bakheet OE,
Fahal LA,
Mohamed AA,
Mohhamedelamin ESW,
Bahar ME,
Attalla HY,
Siddig EE,
Mahmoud NA,
Musa AM,
van de Sande WWJ,
Scherrer B,
Oyieko P,
Egondi T,
Onyango K,
Hata K,
Chu WY,
Dorlo TPC,
Nyaoke BA,
Strub-Wourgaft N,
Zijlstra EE
Download
View PDF
Share
No abstract available
Countries
Sudan
Languages
English
DOI
10.57740/YDzkQTI
Published Date
16 May 2024
Conference
MSF Scientific Day International 2024
Linked Content
Conference Material
|
Video
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
2024 May 16 • MSF Scientific Day International 2024
Similar Content
Video
|
Video
Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
2024 May 16 • MSF Scientific Day International 2024
Loading...
Loading...
View HTML
View PDF
Share
Download
